Analysts Set Trupanion Inc (TRUP) Price Target at $45.63

Trupanion Inc (NASDAQ:TRUP) has been assigned a consensus recommendation of “Buy” from the twelve ratings firms that are currently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $45.63.

A number of equities research analysts recently weighed in on TRUP shares. Raymond James started coverage on Trupanion in a research report on Thursday, September 6th. They set an “outperform” rating and a $46.00 price objective on the stock. Craig Hallum started coverage on Trupanion in a research report on Thursday, July 19th. They set a “buy” rating and a $55.00 price objective on the stock. CL King raised Trupanion from a “neutral” rating to a “buy” rating in a research report on Tuesday, October 2nd. BidaskClub downgraded Trupanion from a “buy” rating to a “hold” rating in a research report on Tuesday, August 14th. Finally, Stifel Nicolaus raised their price objective on Trupanion from $40.00 to $43.00 and gave the company a “buy” rating in a research report on Friday, August 3rd.

In other Trupanion news, Director Murray B. Low sold 3,000 shares of the stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $38.12, for a total value of $114,360.00. Following the completion of the sale, the director now directly owns 189,782 shares in the company, valued at $7,234,489.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Darryl Rawlings sold 4,000 shares of the stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $37.21, for a total value of $148,840.00. Following the completion of the sale, the insider now owns 1,289,989 shares of the company’s stock, valued at $48,000,490.69. The disclosure for this sale can be found here. Over the last quarter, insiders sold 23,450 shares of company stock valued at $783,166. 20.70% of the stock is currently owned by company insiders.

Institutional investors have recently added to or reduced their stakes in the business. SG Americas Securities LLC purchased a new stake in Trupanion in the second quarter valued at about $100,000. First Mercantile Trust Co. purchased a new stake in Trupanion in the second quarter valued at about $142,000. US Bancorp DE raised its stake in Trupanion by 111.8% in the second quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock valued at $175,000 after buying an additional 2,382 shares during the last quarter. Xact Kapitalforvaltning AB purchased a new stake in Trupanion in the second quarter valued at about $224,000. Finally, S&CO Inc. purchased a new stake in Trupanion in the second quarter valued at about $232,000. Institutional investors own 93.62% of the company’s stock.

Shares of TRUP stock opened at $26.64 on Friday. Trupanion has a 1-year low of $22.55 and a 1-year high of $46.70. The stock has a market cap of $827.41 million, a P/E ratio of -380.57 and a beta of 1.08. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.04 and a current ratio of 3.04.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Further Reading: Day Trading – Risk Worth the Reward?

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply